Emilio Martín Mola-rekin lankidetzan egindako argitalpenak (10)

2015

  1. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294

2013

  1. El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones

    Reumatologia Clinica, Vol. 9, Núm. 1, pp. 5-17

2010

  1. Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68

2008

  1. Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients withd-heumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1365-1373

  2. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Arthritis Care and Research, Vol. 59, Núm. 10, pp. 1371-1377

  3. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 10, pp. 1360-1364

2007

  1. Consensus statement on the use of rituximab in patients with rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 2, pp. 143-150

2006

  1. Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period

    Arthritis Research and Therapy, Vol. 8, Núm. 1

2000

  1. Consenso de la Sociedad de Reumatología sobre la terapia con inhibidores de TNF y otros fármacos inductores de remisió en la artritis reumatoide

    Revista Espanola de Reumatologia, Vol. 27, Núm. 8, pp. 352-354

1998

  1. Prospective study of serum and urinary nitrate levels in patients with systemic lupus erythematosus

    British Journal of Rheumatology, Vol. 37, Núm. 9, pp. 972-977